- Home
- SBET vs QNRX Comparison
SBET vs QNRX Comparison
Compare SBET & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBET
- QNRX
- Stock Information
- Founded
- SBET 1995
- QNRX 2018
- Country
- SBET United States
- QNRX United States
- Employees
- SBET N/A
- QNRX N/A
- Industry
- SBET Computer Software: Prepackaged Software
- QNRX Medical/Dental Instruments
- Sector
- SBET Technology
- QNRX Health Care
- Exchange
- SBET Nasdaq
- QNRX Nasdaq
- Market Cap
- SBET 2.3M
- QNRX 2.1M
- IPO Year
- SBET 1997
- QNRX N/A
- Fundamental
- Price
- SBET $0.68
- QNRX $0.62
- Analyst Decision
- SBET
- QNRX Strong Buy
- Analyst Count
- SBET 0
- QNRX 1
- Target Price
- SBET N/A
- QNRX $4.00
- AVG Volume (30 Days)
- SBET 319.5K
- QNRX 486.4K
- Earning Date
- SBET 11-26-2024
- QNRX 11-07-2024
- Dividend Yield
- SBET N/A
- QNRX N/A
- EPS Growth
- SBET N/A
- QNRX N/A
- EPS
- SBET 1.86
- QNRX N/A
- Revenue
- SBET $1,945,422.00
- QNRX N/A
- Revenue This Year
- SBET N/A
- QNRX N/A
- Revenue Next Year
- SBET N/A
- QNRX N/A
- P/E Ratio
- SBET $0.40
- QNRX N/A
- Revenue Growth
- SBET 79.18
- QNRX N/A
- 52 Week Low
- SBET $0.43
- QNRX $0.48
- 52 Week High
- SBET $2.18
- QNRX $6.18
- Technical
- Relative Strength Index (RSI)
- SBET 48.27
- QNRX 43.57
- Support Level
- SBET $0.59
- QNRX $0.60
- Resistance Level
- SBET $1.09
- QNRX $0.77
- Average True Range (ATR)
- SBET 0.11
- QNRX 0.07
- MACD
- SBET -0.00
- QNRX -0.02
- Stochastic Oscillator
- SBET 24.58
- QNRX 12.98
About SBET SharpLink Gaming Ltd.
SharpLink Gaming Inc is a online technology company that connects sports fans, leagues and sports websites to relevant and timely sports betting content. The company owns a performance marketing platform through which the Company owns and operates state-specific web domains designed to attract, acquire, and drive local sports betting and casino traffic directly to its sportsbook and casino partners which are licensed to operate in each respective state. The Company has two operating segments: Affiliate Marketing Services-United States and Affiliate Marketing Services-International. The company generates the majority of the revenue earned from the Affiliate Marketing Services-International segment.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.